Literature DB >> 18922680

Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

Zhi Liu1, Wen Sui, Minglang Zhao, Zhuowei Li, Ning Li, Randy Thresher, George J Giudice, Janet A Fairley, Cassian Sitaru, Detlef Zillikens, Gang Ning, M Peter Marinkovich, Luis A Diaz.   

Abstract

Bullous pemphigoid (BP) is a cutaneous autoimmune inflammatory disease associated with subepidermal blistering and autoantibodies against BP180, a transmembrane collagen and major component of the hemidesmosome. Numerous inflammatory cells infiltrate the upper dermis in BP. IgG autoantibodies in BP fix complement and target multiple BP180 epitopes that are highly clustered within a non-collagen linker domain, termed NC16A. Anti-BP180 antibodies induce BP in mice. In this study, we generated a humanized mouse strain, in which the murine BP180NC14A is replaced with the homologous human BP180NC16A epitope cluster region. We show that the humanized NC16A (NC16A+/+) mice injected with anti-BP180NC16A autoantibodies develop BP-like subepidermal blisters. The F(ab')(2) fragments of pathogenic IgG fail to activate the complement cascade and are no longer pathogenic. The NC16A+/+ mice pretreated with mast cell activation blocker or depleted of complement or neutrophils become resistant to BP. These findings suggest that the humoral response in BP critically depends on innate immune system players.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922680      PMCID: PMC2642586          DOI: 10.1016/j.jaut.2008.08.009

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  57 in total

1.  Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies.

Authors:  J R Stanley; T Tanaka; S Mueller; V Klaus-Kovtun; D Roop
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Cell-mediated immune reaction in the mechanism of blister formation in bullous pemphigoid.

Authors:  Y Takiguchi; O Kamiyama; E Saito; S Nagao; F Kaneko; T Minagawa
Journal:  Dermatologica       Date:  1989

3.  Mononuclear cell infiltrates in bullous disease.

Authors:  M S Nestor; A J Cochran; A R Ahmed
Journal:  J Invest Dermatol       Date:  1987-02       Impact factor: 8.551

4.  Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid.

Authors:  P Bernard; P Aucouturier; F Denis; J M Bonnetblanc
Journal:  Clin Immunol Immunopathol       Date:  1990-03

5.  Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome.

Authors:  L A Diaz; H Ratrie; W S Saunders; S Futamura; H L Squiquera; G J Anhalt; G J Giudice
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Inhibition of eosinophilic inflammation in allergen-challenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium.

Authors:  D H Broide; K Campbell; T Gifford; P Sriramarao
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

7.  Eosinophilic spongiosis in bullous pemphigoid.

Authors:  K Nishioka; K Hashimoto; I Katayama; C Sarashi; T Kubo; S Sano
Journal:  Arch Dermatol       Date:  1984-09

8.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.

Authors:  M Ståhle-Bäckdahl; M Inoue; G J Guidice; W C Parks
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.

Authors:  S A Grando; B T Glukhenky; G N Drannik; E V Epshtein; A P Kostromin; T A Korostash
Journal:  Arch Dermatol       Date:  1989-07

10.  A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

Authors:  Z Liu; L A Diaz; J L Troy; A F Taylor; D J Emery; J A Fairley; G J Giudice
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more
  42 in total

1.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

2.  Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332.

Authors:  F Van den Bergh; S L Eliason; G J Giudice
Journal:  Matrix Biol       Date:  2010-10-26       Impact factor: 11.583

3.  Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.

Authors:  Jarushka Naidoo; Katja Schindler; Christiane Querfeld; Klaus Busam; Jane Cunningham; David B Page; Michael A Postow; Alyona Weinstein; Anna Skripnik Lucas; Kathryn T Ciccolini; Elizabeth A Quigley; Alexander M Lesokhin; Paul K Paik; Jamie E Chaft; Neil H Segal; Sandra P D'Angelo; Mark A Dickson; Jedd D Wolchok; Mario E Lacouture
Journal:  Cancer Immunol Res       Date:  2016-02-29       Impact factor: 11.151

Review 4.  Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.

Authors:  K A N Messingham; H M Holahan; J A Fairley
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid.

Authors:  Kelly N Messingham; Jeffrey W Wang; Heather M Holahan; Rupasree Srikantha; Samantha C Aust; Janet A Fairley
Journal:  Exp Dermatol       Date:  2015-11-23       Impact factor: 3.960

6.  Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice.

Authors:  Tiina Hurskainen; Nina Kokkonen; Raija Sormunen; Joanna Jackow; Stefanie Löffek; Raija Soininen; Claus-Werner Franzke; Leena Bruckner-Tuderman; Kaisa Tasanen
Journal:  J Invest Dermatol       Date:  2014-10-13       Impact factor: 8.551

7.  Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180.

Authors:  Kelly A N Messingham; Amber Onoh; Elizabeth M Vanderah; George J Giudice; Janet A Fairley
Journal:  Hybridoma (Larchmt)       Date:  2012-04

8.  A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid.

Authors:  Kelly A N Messingham; Megan H Noe; Marisa A Chapman; George J Giudice; Janet A Fairley
Journal:  J Immunol Methods       Date:  2009-05-05       Impact factor: 2.303

9.  IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.

Authors:  Yagang Zuo; Flor Evangelista; Donna Culton; Antonio Guilabert; Lin Lin; Ning Li; Luis Diaz; Zhi Liu
Journal:  J Autoimmun       Date:  2016-07-01       Impact factor: 7.094

10.  BP180 dysfunction triggers spontaneous skin inflammation in mice.

Authors:  Yang Zhang; Bin-Jin Hwang; Zhen Liu; Ning Li; Kendall Lough; Scott E Williams; Jinbo Chen; Susan W Burette; Luis A Diaz; Maureen A Su; Shengxiang Xiao; Zhi Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.